Let’s start up with the current stock price of InflaRx N.V. (IFRX), which is $5.02 to be very precise. The Stock rose vividly during the last session to $5.03 after opening rate of $4.54 while the lowest price it went was recorded $4.46 before closing at $4.66.Recently in News on November 15, 2021, InflaRx Announces Positive Data from Phase II IXCHANGE Study with Vilobelimab in ANCA-associated Vasculitis (AAV). Proof of concept established for potential of vilobelimab to reduce use of corticosteroids in AAV patients: vilobelimab demonstrated comparable efficacy to standard of care. You can read further details here
InflaRx N.V. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $6.88 on 01/13/21, with the lowest value was $2.23 for the same time period, recorded on 08/20/21.
InflaRx N.V. (IFRX) full year performance was 26.13%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, InflaRx N.V. shares are logging -27.03% during the 52-week period from high price, and 125.11% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.23 and $6.88.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 821066 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the InflaRx N.V. (IFRX) recorded performance in the market was -0.20%, having the revenues showcasing 100.80% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 220.83M, as it employees total of 49 workers.
Analysts verdict on InflaRx N.V. (IFRX)
During the last month, 0 analysts gave the InflaRx N.V. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.05, with a change in the price was noted +2.05. In a similar fashion, InflaRx N.V. posted a movement of +69.02% for the period of last 100 days, recording 1,985,541 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for IFRX is recording 0.01 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.01.
InflaRx N.V. (IFRX): Technical Analysis
Raw Stochastic average of InflaRx N.V. in the period of last 50 days is set at 80.28%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 67.46%. In the last 20 days, the company’s Stochastic %K was 65.25% and its Stochastic %D was recorded 65.85%.
Let’s take a glance in the erstwhile performances of InflaRx N.V., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -0.20%. Additionally, trading for the stock in the period of the last six months notably improved by 59.87%, alongside a boost of 26.13% for the period of the last 12 months. The shares increased approximately by -3.83% in the 7-day charts and went down by 75.52% in the period of the last 30 days. Common stock shares were driven by 100.80% during last recorded quarter.